XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 50 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $95,000 | -7.8% | 20,975 | 0.0% | 0.00% | – |
| Q4 2020 | $103,000 | +15.7% | 20,975 | +40.0% | 0.00% | – |
| Q3 2020 | $89,000 | +154.3% | 14,979 | +13.5% | 0.00% | – |
| Q2 2020 | $35,000 | +34.6% | 13,203 | -1.4% | 0.00% | – |
| Q1 2020 | $26,000 | -72.3% | 13,396 | 0.0% | 0.00% | – |
| Q4 2019 | $94,000 | -4.1% | 13,396 | +33.8% | 0.00% | – |
| Q3 2019 | $98,000 | -14.8% | 10,014 | 0.0% | 0.00% | – |
| Q2 2019 | $115,000 | – | 10,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Investment Research & Advisory Group, Inc. | 803 | $2,000 | 0.00% |